Literature DB >> 2418012

Hydrolysis of substance P and its analogs by angiotensin-converting enzyme from rat lung. Characterization of endopeptidase activity of the enzyme.

H Yokosawa, S Endo, Y Ohgaki, J Maeyama, S Ishii.   

Abstract

Hydrolysis of substance P and nine kinds of substance P analogs by angiotensin-converting enzyme highly purified from rat lung was examined by using amino-group fluorometry and high-performance liquid chromatography. The enzyme hydrolyzed substance P and several analogs, notwithstanding that they did not contain free C-terminal residues. The analyses of cleavage products separated by high-performance liquid chromatography indicated that the enzyme hydrolyzed substance P and its analogs mainly at the bond between Phe8-Gly9 and also at another bond, possibly between Gly9-Leu10, to a lesser extent by an endopeptidase action, followed by successive release of dipeptides by a dipeptidyl carboxypeptidase action. The analogs that had D-amino acid residues substituted at the presumed cleavage sites were scarcely hydrolyzed. It was further found that (Pyr6)-fragment (6-11) was hydrolyzed by the enzyme more efficiently than the other fragment-type analogs and was cleaved at a single bond by the endopeptidase activity of the enzyme. Therefore, this fragment was used as a substrate in order to characterized the endopeptidase activity of the enzyme by employing fluorometry. The activity was dependent on chloride ion, and was inhibited by captopril, MK-421, and EDTA. Thus, the endopeptidase activity of the enzyme showed properties similar to those of the dipeptidyl carboxypeptidase activity of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2418012     DOI: 10.1093/oxfordjournals.jbchem.a135396

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

1.  Bronchoconstrictor and hypotensive effects in relation to pharmacokinetics of tachykinins in the guinea-pig--evidence for extraneuronal cleavage of neuropeptide K to neurokinin A.

Authors:  C R Martling; E Theodorsson-Norheim; I Norheim; J M Lundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

2.  Angiotensin-converting enzyme inhibition, cough and the serum concentration of substance P.

Authors:  H Thysell; K E Andersson; S I Andersson; R Ekman
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Peptidase modulation of the pulmonary effects of tachykinins in tracheal superfused guinea pig lungs.

Authors:  M A Martins; S A Shore; N P Gerard; C Gerard; J M Drazen
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

4.  The effect of local converting enzyme inhibition on the dilator response to substance P in the human forearm.

Authors:  N Benjamin; D J Webb
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

5.  Resolution of ACE inhibitor cough: changes in subjective cough and responses to inhaled capsaicin, intradermal bradykinin and substance-P.

Authors:  W W Yeo; I G Chadwick; M Kraskiewicz; P R Jackson; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1995-11       Impact factor: 4.335

6.  The effects of enalapril and sulindac on the dermal response to substance P and neurokinin A.

Authors:  R E Ferner; F Kamali; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

Review 7.  Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery.

Authors:  J P Bai; G L Amidon
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

8.  Substance P increases sympathetic activity during combined angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibition.

Authors:  Jessica K Devin; Mias Pretorius; Hui Nian; Chang Yu; Frederic T Billings; Nancy J Brown
Journal:  Hypertension       Date:  2014-02-10       Impact factor: 10.190

9.  Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study.

Authors:  Christopher D Verrico; Colin N Haile; Richard De La Garza; Kenneth Grasing; Thomas R Kosten; Thomas F Newton
Journal:  Int J Neuropsychopharmacol       Date:  2016-07-05       Impact factor: 5.176

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.